Psychedelic News

We welcome back Nick Levich for our "Ask a Psychedelic Professional" series and as part of our "Ask a Psychedelic Guide" episode.

The War On Drugs May Finally Be Over: Decriminalization Legislation Comes to Congress

Representatives Cori Bush and Bonnie Watson Coleman have introduced legislation to end the federal war on drugs once and for all.

Study Finds Synthetic Psilocybin Did Not Adversely Affect Cognitive Function

Is synthetic psilocybin as effective as the real thing? A new study looks at the risks and benefits of taking this lab-made psychedelic.

University of Calgary Creates Canada’s First Chair for Psychedelic Research

Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.

Psilocybin May Treat Phantom Limb Syndrome

80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.

New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.

Peter Thiel-Backed Atai Life Sciences Announces IPO With $2 Billion Valuation

Atai Life Sciences is the latest psychedelic company to announce plans to IPO. The Peter Thiel-backed biotech startup is valued at more than $2 billion.

Do Psychedelics Hold the Key to Explaining Near-Death Experiences?

New research into psychedelics shows it may help scientists better understand the phenomenon known as near-death experiences.

Psychedelic Business Spotlight: June 11, 2021

This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.

First-of-Its-Kind Genetic Psychedelic Test Kit Now Available In U.S.

The first genetic psychedelic test kit is now available in the U.S. The kits are designed to help users know how they'll respond to psychedelics.

Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics

Seattle city council members are being asked to review decriminalizing psychedelics.

Psilocybin Shows Promise As Treatment for Migraines

A new investigation into treatment for migraines spotlights the psychedelic psilocybin mushroom as a promising prospect.

Connecticut Governor Signs Psychedelic Reform Deal

Connecticut has become the newest state to consider reform proposals regarding psychedelic medicines.

LSA Is Nature's LSD: Meet the Unsynthesized Psychedelic Found In 1,000 Flowers

LSA Is Nature’s LSD: Meet the Unsynthesized Psychedelic Found In Ancient Flowers

What is LSA? Meet the unsynthesized psychedelic similar to LSD but found abundantly in nature and prized around the world.

Interview With Fruiting Bodies Collective

We chat with Rebecca Martinez and Elan Hagens who are the Founders of Fruiting Bodies Collective.

Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With Psychedelics

A new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with psilocybin.

Field Trip Health Begins Trading on TSE, Sets Sights on Nasdaq

Psychedelic lifestyle brand Field Trip Health is now trading on the Toronto Stock Exchange under the symbol "FTRP".

Could Psychedelic-Assisted Therapy Improve Your Mental Health? Here's What to Know

What Is Psychedelic-Assisted Therapy? Here’s Everything You Need to Know

What is psychedelic-assisted therapy and does it work? Here's everything you need to know about a new approach to mental health.

GH Research Is Taking its Psychedelic 5-MeO-DMT 'Toad Venom' Public

GH Research Is Taking Psychedelic 5-MeO-DMT ‘Toad Venom’ Public

GH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued at more than $100 million.

AI Tech-Led Psychedelic Therapy Platform Nue Life Health Raises $3.3 Million

Nue Life Health is a new therapy platform relying on AI and music as well as psychedelics for customized healing.

Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From Bacteria

PsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of mushrooms.

Psychedelic Business Spotlight: June 4, 2021

This week in psychedelic business: Mindset Pharma's new research, synthetic ibogaine, and the Western Hemisphere gets its first “smart shop.”

New York Bill Proposes State-Sponsored Psychedelic Research Institute

New York is looking to explore psychedelic research through the formation of a new institute to investigate the healing potential.

California Senate Passes Psychedelic Decriminalization Bill

California is poised to become the second U.S. state to decriminalize possession and use of psychedelics following Oregon.

How a Psilocybin Retreat Changed Everything I Knew About Psychedelics

Here's how a legal psilocybin truffle retreat in the Netherlands changed this author's relationship with psychedelics.

BIPOC Medicine Healing with the Ancestor Project

Charlotte James and "Dre” Wright of The Ancestor Project chat with our Director of Content, Jill Ettinger.

Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.

‘PSY’ Becomes First U.S.-Listed Psychedelic ETF

Defiance Next Gen Altered Experience ETF began trading Friday on the New York Stock Exchange under the symbol PSY.

Why Deepak Chopra Wants to Shift Public Perception About Psychedelics

Spiritual leader and healer Deepak Chopra is focused on bringing attention to psychedelics as a means to heal trauma.

Psychedelic Business Spotlight: May 28, 2021

This week in psychedelic business news: NeonMind's Medical Advisory Board, Mynd's public listing, and a new study supports novel use of DMT.

Psychedelic Platform Field Trip Health Gets Uplisting Conditional Approval for Toronto Stock Exchange

Psychedelic healing platform Field Trip Health has received conditional approval to uplist to the Toronto Stock Exchange.

Psychedelic Drug Development Company Mynd Life Sciences Goes Public on the CSE

Psychedelic drug development company Mynd Life Sciences has gone public on the CSE.

Attorneys General, Organizations, Specialists Sue DEA for Access to Psilocybin for Terminally Ill Patients

Policy, Treatment

A coalition of activists, organizations, and attorneys general are suing the DEA on behalf of terminally ill patients seeking psilocybin treatment.

Israelis and Palestinians Turn to Ayahuasca to Heal Conflict Wounds

New research has investigated the psychedelic ayahuasca in peace-building between conflict regions such as Israel and Palestine.

In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").ya Health's Co-Founder and CEO, David Champion, discusses the importance of data and analytics in the growing psychedelic community.

Research to Look at Psychedelics for Autism Treatment

New research from Nova Mentis will explore the potential benefits of psychedelics in treating autism spectrum disorders.

FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

The FDA has approved a novel study allowing therapists who treat PTSD to take MDMA to better understand the treatment benefits.

What Is Changa? The Psychedelic You’ve Likely Never Heard Of (Yet)

What is changa? This DMT-containing psychedelic is gaining more recognition for its benefits, but you may still have not yet heard of it.

Texas Senate Approves Psychedelic Research Legislation Aimed at Military Veterans

Texas has moved closer to legal psychedelic research for PTSD military veterans after the state senate approved the legislation.

Enveric Biosciences Acquires Psychedelic Drug Discovery Platform MagicMed Industries

Cannabis-focused Enveric Biosciences will acquire Canadian psychedelic drug discovery platform MagicMed Industries.

California Bill Decriminalizing Psychedelics Moves Closer to Full Senate Vote

California legislation aimed at decriminalizing psychedelics is moving closer to a full Senate vote that could make it the 2nd state to pass such a measure.

Psychedelic Passage Bridges Gap Between Guide and Journeyer

There’s a lot to ensuring a safe psychedelic trip. Take the wrong dose, be in the wrong setting, or not have the right person beside you as you go through the experience—whether it’s your first time or your hundredth—can be risky. But…

Psychedelic Business Spotlight: May 21, 2021

This week in psychedelic business news: Therapists cleared to try MDMA, alternative medicine guru promotes psychedelic therapy, and the Swiss green-light new mescaline study. On the heels of the recently released trial data showing how MDMA-assisted…

Kristen Bell Used Psychedelics to Treat Depression

Actress Kristen Bell Used Psychedelic Mushrooms to Treat Depression

Actress Kristen Bell says psychedelic mushrooms have helped her to treat her depression and anxiety symptoms.

Shark Tank’s Kevin O’Leary Deep Dives Into Psychedelics

Shark Tank investor Kevin O'Leary is a big fan of psychedelics. Here's everything you need to know.

Lamar Odom Documentary About His Recovery Through Psychedelics Makes Its Debut

Former NBA star Lamar Odom details his recovery from substance abuse with the aid of psychedelic medicine in a new documentary.

PharmaDrug Launches E-Store Positioned for U.S. Psychedelic Sales

PharmaDrug is bringing an online shop to the U.S. for sales of functional mushrooms and psychedelics once legal.

What Is MDMA? Meet the Psychedelic Treatment That Could Make PTSD Obsolete

What is MDMA? This psychedelic is showing promise as a treatment for PTSD and depression.

Interview With David Champion

Maya Health's Co-Founder and CEO, David Champion, discusses the importance of data and analytics in the growing psychedelic community.

Is There a Case for Keeping Psychedelics Illegal? Ethics, Conservation, and Indigenous Rights

Culture, Policy

If decriminalization efforts strain natural plant and animal medicine populations, should psychedelics remain illegal?

Algernon to Become the First Company in the World to Study DMT for Stroke Patients

Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.

What Is Psilohuasca? How and Why This Psychedelic Combo Is Going Mainstream

What is psilohuasca? This psychedelic combo marries MAO inhibitors with psilocin for an extended journey into healing.

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.

Could Psychedelics Cure Color Blindness? New Data Sees a Bright Future

Could psychedelics help people suffering from color blindness? New research sees great potential with lsd and psilocybin.

The Essence Institute Explores Psilocybin Truffle Medicine In the Netherlands

In the heart of the Netherlands, legal psilocybin truffle retreats help seekers explore the benefits of psychedelics at the Essence Institute.

The World Boxing Council Is the First Global Sports Governing Body to Research Psychedelic Treatment for Brain Injuries

Treating traumatic brain injury with psychedelics will get a closer study in a partnership between the World Boxing Council and Wesana Health.

Silo Wellness to Host Psychedelic Retreat Exclusively for LGBTQIA+ Community

In honor of Pride Month, Silo Wellness is launching its first-ever LGBTQIA+ psychedelic retreat in Jamaica.

Oregon’s Democratic Party Endorses Legalization of Psilocybin

Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression

In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.

Psychedelic Business News Spotlight: May 14, 2021

This week in psychedelic business news: Therapeutic uses of salvinorin A, a 5-MeO-DMT retreat, and World Boxing Council explores psychedelics.

MDMA Study Finds More Than 60% Success Rate in PTSD Patients

New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a clinical setting.

Daniel Carcillo's Wesana Health Goes Public on CSE

Daniel Carcillo’s Psychedelic Life Sciences Company Wesana Health Goes Public on CSE

Daniel Carcillo's psychedelic life sciences company is now trading on the Canadian Securities Exchange.

Interview With Timothy Ko

CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions.

Psychable Promotes Psychedelic-Assisted Therapy During Trauma Awareness Month

For Trauma Awareness Month the online platform Psychable is promoting psychedelic-assisted therapy for treating a number of conditions.

DMT-Focused Psychedelic Company Small Pharma Launches on TSX Venture Exchange

DMT-focused psychedelic therapy company Small Pharma is listing on the Canadian TSK Venture Exchange as it ramps up its offerings.

Singapore Begins Administering Ketamine-Type Therapy for Depression

Spravato, the ketamine-based therapy produced by Johnson & Johnson, is now legal to use as therapy for depression in Singapore.

Psychedelic Investment Platform Clarify Pharma to Go Public With £10.5 Million Valuation

The psychedelic investment platform Clarify Pharma is expecting to go public on the AQSE with a valuation of £10.5 million.

Mike Tyson Invests In Psychedelic Wellness Company Wesana Health

Business, Culture

Former heavyweight boxing champion Mike Tyson announced he's an investor in psychedelic wellness company Wesana Health.

Advocating for Psychedelic Medicine Is Personal for Ashley Lukens

Psychedelics Helped Her Beat Cancer. Now Ashley Lukens Is Paying It Forward.

Advocate and activist Ashley Lukens has her reasons for supporting psychedelic medicine. They helped her battle cancer. Now she's returning the favor.

Ketamine’s Rapid and Robust Effects Beneficial for Depressed, Suicidal Patients, Expert Says

New Treatment Potential for Depressed, Suicidal Patients With Ketamine, Says Expert

There's new hope for depressed and suicidal patients with ketamine therapy, says University of Alabama doctor Richard C. Shelton.

Psychedelic Business News Spotlight: May 7, 2021

This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands is now Braxia Scientific Corp, and more.

NIMH Addresses Critical Need for Fast-Acting Interventions for Severe Suicide Risk

NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, Esketamine

New treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine therapies.

Ketamine Effectively Treats Persistent Migraine Headaches: Study

A nasal spray of ketamine proved to be highly effective at treating a type of migraine called refractory migraines, according to a new study.

MindMed’s Project Angie to Explore LSD for Pain Conditions

MindMed’s Project Angie to Explore LSD for Chronic Pain Treatment

Psychedelic life sciences company MindMed is exploring LSD as a means of pain management.

Canada Approves New Leaf’s Bid to Build First-Of-Its-Kind Psilocybin Lab

New Leaf Canada has received permission from Health Canada to build a first-of-its-kind laboratory to produce and study psilocybin and psilocin.

Psychedelic Companies Combine Forces to Create Virtual Reality Experience

A new psychedelic VR experience is coming thanks to a partnership between Lobe Sciences and Virtual Psychedelics.

Promising Results from First Phase-3 Trial Investigating MDMA-Assisted Therapy for PTSD

The first phase-3 trial of its kind investigating MDMA for PTSD is showing promising results.

Interview With Joshua White

Fireside Project’s Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.

Researchers Discover Therapeutic Potential of Non-Hallucinogenic Psychedelic

Researchers have identified a psychedelic with no hallucinogenic characteristics using a new sensor.

Former NFL Player Kerry Rhodes Discusses Ayahuasca Experience With Tamron Hall

Actor and former NFL safety Kerry Rhodes says the psychedelic compound ayahuasca has helped him recover from brain injuries.

Maine Bill Seeks to Legalize Therapeutic Use of Psilocybin

Maine could soon become the second U.S. state to legalize the use of medicinal psilocybin for therapeutic use.

Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study

A follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses with use of psilocybin treatment.

Psychedelic Business News Spotlight: April 30, 2021

This week in psychedelic business news: Cybin’s experimental psychedelic takes aim at alcohol use disorder, Numinus seeks volunteers for its natural psilocybin extract, and another psychedelic company trades on Nasdaq. Toronto-based…

First-of-Its-Kind 5-MeO-DMT Psychedelic Training Underscores New Research Potential

Beckley Psytech and Fluence have partnered on a first of its kind training for 5-meo-DMT psychedelic treatment and therapy.

PharmaTher Files Patent on Ketamine for Diabetes and Obesity Treatment

Ketamine may be a useful treatment for diabetes and obesity, according to a new patent filed by psychedelic company PharmTher.

Should Psychedelics Be Legal? Experts Weigh In

Culture, Policy

Should psychedelics be legal? That was the topic of an expert-led debate featured on the Intelligence² Debates podcast.

Interview With Joshua Bartch

Mydecine Innovations Group’s Director, CEO & Co-Founder, Joshua Bartch chats with our Director of Content, Jill Ettinger.

Who Is Stanislav Grof? Meet the Psychedelic Pioneer and Father of Holotropic Breathwork

Stanislav Grof is one of the earliest pioneers in psychedelics and holotropic breathwork.

New Campaign to Raise Awareness of Healing Power of Psychedelics for Veterans

A new campaign, #natureheals promotes psychedelics for veterans suffering from PTSD and other mental health issues.

Kevin O'Leary-Backed MindMed Is 2nd Psychedelic Company to List On Nasdaq

Kevin O’Leary-Backed MindMed Will Be 2nd Psychedelic Company to List On Nasdaq

MindMed will take its Kevin O'Leary-backed platform onto the Nasdaq Tuesday as only the 2nd psychedelic company to do so.

Fireside Project Launches Psychedelic Support Hotline

Fireside Project Launches Psychedelic Peer Support Hotline

A new psychedelic hotline, the Fireside Project, aims to provide peer support for people under the influence of psychedelic substances.

The Benefits of Peyote: Ancient Wisdom, Modern Medicine

The benefits of peyote have been prized by Indigenous cultures for millennia. Now they're showing promise in modern medicine, too.

Interactive Dreaming May Hold Similar Therapeutic Potential As Psychedelics

Interactive or lucid dreaming may be as beneficial for mental health as lucid dreaming, new research finds.

Psychedelic Business News Spotlight: April 23, 2021

This week in psychedelic business news: Atai to raise $100 million, Silo's psilocybin nasal spray, and more.

How a Psychedelic Experience Led to the Extinction Rebellion

How a Psychedelic Experience Led to the Formation of the Extinction Rebellion

A psychedelic experience helped create the environmental activist organization known as Extinction Rebellion.

Study Looking at Ibogaine for Opioid Addiction

New Study Will Look At Ibogaine Treatment for Opioid Addiction

A potent tool in the battle against opioid addiction, ibogaine treatment is the subject of a new study in the UK.

Art, Ayahuasca, And Climate Change: Can We Heal Our Way Back to a Healthy Planet?

Art, Ayahuasca, And Climate Change: Can We Heal Our Way to a Healthy Planet?

Can psychedelics like ayahuasca along with art be healthy ways to heal our planet and make us advocates in the fight against climate change?

Psychedelic Start-Up Atai Life Sciences to Raise $100 Million in IPO, 2nd to List on Nasdaq

Atai Life Sciences is now the second psychedelic company to list on Nasdaq, with plans to raise $100 million for its IPO.

11 Celebrities Whose Lives Were Changed by Psychedelics

From Sir Paul McCartney to Joe Rogan, these celebrities all credit psychedelics with changing their lives.

Interview With Rabbi Zac Kamenetz

Founder and CEO of Shefa, and Co-Founder of the Jewish Psychedelic Summit, Rabbi Zac Kamenetz, speaks about the upcoming summit and the connection between Judaism and psychedelics.

Interview With Douglas K. Gordon

CEO of Silo Wellness, Douglas K. Gordon, speaks about the company’s expansion to the Frankfurt Exchange and the recent collaboration with the Bob Marley Estate.

Psilocybin’s Relationship with Creativity a ‘Complicated’ Affair, Study Finds

New research points to a connection between psilocybin mushrooms and creativity.

Former Texas Gov. Rick Perry Champions Psychedelic Therapy for PTSD

Former Texas Governor, the Republican Rick Perry, is supporting legislation for psychedelic therapy to help veterans with PTSD.

Psilocybin As Effective as Lexapro in Treating Depression: Study

The first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising.

Bicycle Day Celebrates First Human LSD Trip

What Is Bicycle Day? Celebrating the First Human LSD Trip

April 19th is Bicycle Day — the first documented case of a human experience on LSD taken by chemist Albert Hoffman.

Interview With Stephen Murphy

Stephen Murphy, Co-Founder of Prohibition Partners, chats about the upcoming PSYCH Investor Summit taking place on April 21, 2021.

Psychedelic Business News Spotlight: April 16, 2021

This week in psychedelic business news:psilocybin’s genome sequencing explored, psychedelics meet artificial intelligence, and more.

Lower Doses of Psilocybin May Still Have Antidepressant Effects

Psilocybin taken at low doses could have powerful antidepressant effects, according to new research findings.

GH Research Raises $125 Million to Fund DMT Treatment for Depression

GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment.

First-Ever Jewish Psychedelic Summit Planned for May 2-3

The first conference of its kind, the Jewish Psychedelic Summit, will explore the connection between psychedelics and Judaism.

Silo Wellness Expands Shareholder Base to Europe

Toronto's Silo Wellness is now trading on the German Stock Exchange as demand for psychedelic treatments expands.

Can You Predict a ‘Bad’ Psychedelic Trip? And Can You Stop One Once It Starts?

For all the benefits in taking psychedelic substance like psilocybin, there is the risk of having a bad trip.

Daniel Carcillo’s Psychedelic Startup Wesana Health Raises More Funds, On Track to Go Public

Business, Culture

Former NHL player Daniel Carcillo's psychedelic startup Wesana Health is preparing to take the company public.

Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood Abuse

Adults with depression who were abused or neglected as children responded better to intravenous ketamine therapy than depressed adults who were not mistreated, according to a poster presentation and discussion at the recent Anxiety and Depression…

Psychedelics Company Atai Adds Brain-Computer Interface for Mental Health Treatment

Atai Life Sciences is working to combine psychedelics with brain-computer interfaces for mental health treatment.

Psychedelic Business News Spotlight: April 9, 2021

This week in psychedelic business news: a psilocybin delivery system for brain inflammation, a genetic test to predict your psychedelic-assisted therapy experience, and a potential first treatment for a debilitating form of schizophrenia.

The Company of Others: How Shared Psychedelic Experiences Influence Outcomes

Does taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.

Psychedelic Conference to Explore Promising Therapies for Veterans, First Responders

The Heroic Dose conference will explore the use of psychedelic therapies to treat post-traumatic stress disorder, substance abuse, and suicide among military veterans and first responders.

Mydecine Prepares to Present Four Novel Psychedelic Candidates

Business, Treatment

Colorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety and depression.

Yale to Study Psilocybin for Cluster Headaches

Psilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.

California Moves Closer to Decriminalizing Psychedelics

With 2 cities in the Golden State already decriminalizing psychedelics, could the rest of California be next?

Hawaii Establishes Workgroup to Investigate Psilocybin Therapy

Hawaii’s Senate unanimously voted to establish a working group to ensure the safety, accessibility, and affordability of psilocybin.

Interview With Dr. Joseph Tucker

MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.

Interview With Dustin Robinson

Mr. Psychedelic Law’s Co-Founding Partner, Dustin Robinson, talks about how he became involved with the medicinal psychedelic space.

Study Investigates Optimal Dosing for MDMA

Potential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a new study published in the latest edition of the Journal of Psychopharmacology.

A Third Massachusetts City Just Decriminalized Psychedelics

Policy, Uncategorized

Following Somerville and Cambridge, Northampton, Massachusetts, is the latest city to decriminalize certain psychedelics.

Psychedelic Business News Spotlight: April 2, 2021

This week in psychedelic business news: cannabis dives in, ketamine delivery, and psilocybin for autism anxiety.

How Field Trip Health Is Leading the Psychedelic Market Boom

Field Trip Health is brining psychedelics to the forefront of mental health wellness.

UCSF Launches New Psychedelic Research Division

Psychedelic research is coming to the University of California in a new division to study MDMA.

Mass General to Study Psilocybin at New Psychedelic Research Center

Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.

Meditation and Psychedelics Have Similar Effects On Our Brains: Do We Need Both?

The synergy between meditation and psychedelics has been long understood. Now, as research explores the benefits, do we need both?

Interview With Nick Levich

Psychedelic Passage’s Co-Founder and Facilitator, Nick Levich, talks about the function, purpose and importance of a trip sitter during a psychedelic experience.

Interview With Pierre Bouchard

Psychotherapist, Pierre Bouchard talks with our Director of Content, Jill Ettinger.

Use of Psychedelic Shows Correlation With Better Overall Physical Health

Use of Psychedelics Show Correlation With Better Overall Physical Health

Do psychedelics improve health? A new study finds a correlation between user health and psychedelic experiences.

Are Stereotypes Around Psychedelics Slowing Down Research?

Psychedelics come with history as party drugs. Are these stigmas slowing down progress?

Minnesota Gets Its First Psychedelic Clinic

Minnesota Gets Its First Psychedelic Medicine Clinic

The first psychedelic therapy clinic has opened in Minnesota. The Institute for Integrative Therapies will provide ketamine-assisted therapy.

Listening to Ecstasy: Can This Man Normalize MDMA for Seniors?

New Research Investigates Psilocybin as OCD Treatment

Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).

New Guidance Released for Ketamine, Esketamine Therapy Use

Suggested guidances for use of ketamine and esketamine therapy have been published in the American Journal of Psychiatry.

Psychedelic Use Linked to 20% Decreased Hypertension Risk, Study Finds

Psychedelic use may help to decrease the risk of hypertension, according to new research.

Psychedelic Business News Spotlight: March 26, 2021

This week in psychedelic business news sees pharmaceutical giant Merck enter the arena, psilocybin research, and more.

New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects

Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.

MAPS Founder Rick Doblin Talks MDMA Research for PTSD With Actress Mayim Bialik

MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik

Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research.

University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine

The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine.

Interview With Dr. Steven Mandel

In this episode of the Psychedelic Spotlight podcast, we have the distinct privilege of speaking with one of the foremost experts in ketamine-assisted therapy, Dr. Steven L. Mandel, Founder and President of Ketamine Clinics Los Angeles.

Interview With Sacha Hebbert

Mind Cure Health's Senior Product and Marketing Manager, Sacha Hebbert, talks about the company's recent launch of its product sales division.

Former Presidential Candidate Andrew Yang Wants to Decriminalize Psilocybin Mushrooms

Culture, Policy

Former presidential candidate Andrew Yang wants to decriminalize psilocybin. And if he becomes mayor of New York City, that could happen.

Big Pharma Giant Merck Partners With Psychedelic Research Company Novamind

Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.

Women Are More Likely to Use Psychedelics Than Men

Survey: Women Use Psychedelics More Often Than Men

A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.

Australia to Study Psilocybin for Meth Addiction

New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin.

Can Psilocybin Cure Obesity? NeonMind Biosciences Thinks It Just Might

Can psilocybin help cure obesity? NeonMind Biosciences is hopeful. The company is researching the benefits of psychedelics for eating disorders.

Advocacy Group Launches Campaign to Legalize Psychedelics in Michigan

Michigan could follow in the steps of Oregon to legalize psychedelics for therapeutic use. Ann Arbor already decriminalizes possession.

Psychedelic Business News Spotlight: March 19, 2021

This week in psychedelic business news, quick dissolve LSD, novel psychedelic molecules move into investigational studies, and more.

These 24 Psychedelic Patents Are Paving the Way for Medicine 2.0

Business, Research

Patents of psychedelic substances are paving the way for new research and treatment options for a variety of diseases.

Establishing the Ethical Imperative in Psychedelic Medicine

Researchers to Hone In On Most Therapeutic Doses of LSD

New research is looking into the optimal dose of LSD to further enhance the therapeutic benefits of the psychedelic.

Oregon Announces Creation of the Psilocybin Advisory Board

The first state to legalize therapeutic use of psilocybin, Oregon now has an advisory board to help build its regulations.

Psychotherapist Kelli Foulkrod Takes a Holistic Approach to Trauma Treatment With Psychedelics

Psychotherapist Kelli Foulkrod uses psychedelics with her patients as part of her holistic treatment to mental health issues.

New York Bill Would Decriminalize Psychedelics

New York Bill Would Decriminalize Psilocybin

Proposed legislation in the state of New York would decriminalize psilocybin, the psychedelic compound in some types of mushrooms.

How The Conscious Fund Is Changing Perceptions About Psychedelics

UK venture capital fund The Conscious Fund is working to make psychedelics more accessible and functional in various capacities.

Wshington DC Psychedelic Decriminalization

Psychedelics Officially Decriminalized In Washington D.C.

After voters approved a measure that decriminalized psychedelics in Washington D.C. last November, the measure is now in effect.

Interview With Joël Brierre

In this episode of the Psychedelic Spotlight podcast we speak with Joël Brierre who is the founder & CEO of Kaivalya Kollectiv.

Ketamine Retreats Focus on Healing Power of Nature

Silo Wellness Ketamine Retreats to Focus on Healing Power of Nature

Silo Wellness Inc., a wellness company in the psychedelics and functional mushroom space, is offering ketamine-assisted psychedelics wellness retreats

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.

Small Pharma Clinical Trials to Study DMT for Treatment-Resistant Depression

Small Pharma is going into clinical trials to look at DMT for depression relief. The UK company says it believes benefits will be immediate.

Vermont Bill Would Decriminalize Psychedelics In Interest of Public Health

Vermont is looking to decriminalize psychedelics as part of its efforts to improve public health in the state.

Silo Wellness to Launch a Bob Marley-Labeled Line of Psilocybin Mushrooms

The family of Bob Marley and Silo Wellness have teamed up for the first line of commercial psilocybin mushrooms.

Interview With Richard Skaife

In this episode of the Psychedelic Spotlight podcast we speak with Richard Skaife who is the Co-Founding Partner of The Conscious Fund.

Psychedelic Business News Spotlight: March 12, 2021

This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more.

Are the Subjective Effects of Psychedelics Necessary for Therapy?

Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores.

Canada Expands Psychedelic Approvals for Numinus

Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution.

Algernon to Investigate DMT Microdose for Stroke Treatment

Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients.

Ketamine Therapy May Help Slow Progression of ALS

New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis.

Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression

Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.

Beckley Psytech Explores Psilocybin for Headache Treatment

A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.

In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing and training space.

Atma Journey Centers Opens First Clinic In Calgary, Alberta

In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing and training space.

How One Dying Man Received Canada's First End of Life Psilocybin Treatment

Canada’s First End of Life Psilocybin Treatment Brought Peace to Terminal Man

Tony White may have lost his battle with cancer, but becoming the first end of life recipient of psilocybin treatment has changed everything.

Are ‘Magic’ Psilocybin Truffles the Fountain of Youth? New Study Looks at Anti-Aging Benefits

New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.

North America Is Poised to Take the Lead In Emerging Psychedelic Drug Market

North America Is Poised to Take the Lead In Emerging Psychedelic Drugs Market

Business, Policy

The psychedelic drugs market is finding a strong base in North America, according to new data. The U.S. and Canada in particular are supporting its expansion.

New App Creates Psychedelic Experience Without the Need for Substances

Can An App Give You a Psychedelic Experience Without Taking Drugs? Lumenate Says Yes

Business, Culture

Lumenate is an app that simulates a psychedelic experience without the need for illegal substances.

Minority Veterans Organization Urges Congress to Loosen Restrictions on Psychedelic Therapies

A minority veterans organization wants access to psychedelic therapies for PTSD and depression. It's urging Congress to take action.

Are Microdosing Benefits Real? A New Study Says It May All Be In Your Mind

MIcrodosing with psychedelics is gaining in popularity but new research says the placebo effect worked just as well.

Defiance Just Launched the World's Second Psychedelic-Focused ETF

Defiance Just Launched the World’s Second Psychedelics-Focused ETF

Defiance has launched the world's second psychedelics-focused ETF as investing in psychedelic therapy and treatment accelerates.

Missouri Bill Would Give Terminally Ill Patients Access to Psychedelic Therapies

Policy, Treatment

Missouri residents with terminal or debilitating conditions may soon be able to access psychedelics under a new bill.

What are Psilocybin Truffles? Are They Safe?

Mushrooms have garnered plenty of attention for their psychedelic properties. Now the mushroom's ts lesser-known cousin, psilocybin truffles is in the spotlight.

How Do Hallucinogens Work? The Complete Guide to Psychedelic Benefits

Whether trying psychedelics recreationally or clinically, you may wonder: just how do hallucinogens work? Here's the guide to what to expect.

Psychedelic Business News Spotlight: March 5, 2021

This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.

Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion

Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.

Michael Pollan Explores More Psychedelics In New Book: This Is Your Mind on Plants

New York Times bestselling author Michael Pollan explores mescaline, opium, and caffeine in his forthcoming book "This Is Your Mind on Plants".

Ask a Psychotherapist With Kelli Foulkrod

We debut our first ever "Ask a Psychotherapist" segment where we take questions submitted by our listeners and have Kelli Foulkrod, a transpersonal psychotherapist, answer them.

UFC Explores Psychedelic Therapy for Brain-Injured Fighters

UFC is exploring psychedelic therapy for helping its fighters with brain injuries overcome the short and long-term issues.

Former UFC Fighter Ian McCall’s Reeducation on Psychedelics Comes With a Puppet Show

It's been nearly 3 years since Ian McCall stopped UFC fighting. Now, he's bringing psychedelics mainstream with the help of puppets.

Psychedelic Business News Spotlight: February 26, 2021

This week in psychedelic business news, Field Trip upsizes its bought deal, psilocybin truffles head to Brazil, another company goes public, and more.

First Of Its Kind $10 Million Psychedelic Research Center Comes to NYU

‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYU

Business, Research

NYU will open a $10 million psychedelic research center to further its work in using psychedelic substances to treat mental health issues.

How Music Plays a Role In Psychedelic Experiences

Should You Listen to Music During Psychedelic Treatments? How Sounds Impact the Experience

Does listening to music under the influence of psychedelics impact the experience? Here's what you need to know.

Interview With Christi Myers

In this episode of the Psychedelic Spotlight Podcast, our Director of Content catches up with Christi Myers, founder and director of Flow Wellness. Christi discusses her career as a paramedic and how that translates into her work now, helping people heal traumas with ketamine therapy.

Interview With Ronan Levy